Epigral Ltd reported a 111% increase in net profit to Rs 81 Crore for Q2 FY2025 and announced plans to expand its CPVC capacity to 150,000 TPA and Epichlorohydrin capacity to 100,000 TPA, making them the largest facilities of their kind in the world and India, respectively.